• English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • español 
    • English
    • Ελληνικά
    • Deutsch
    • français
    • italiano
    • español
  • Login
Ver ítem 
  •   DSpace Principal
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Ver ítem
  •   DSpace Principal
  • Επιστημονικές Δημοσιεύσεις Μελών ΠΘ (ΕΔΠΘ)
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ.
  • Ver ítem
JavaScript is disabled for your browser. Some features of this site may not work without it.
Todo DSpace
  • Comunidades & Colecciones
  • Por fecha de publicación
  • Autores
  • Títulos
  • Materias

Progression into sepsis: An individualized process varying by the interaction of comorbidities with the underlying infection

Thumbnail
Autor
Sinapidis D., Kosmas V., Vittoros V., Koutelidakis I.M., Pantazi A., Stefos A., Katsaros K.E., Akinosoglou K., Bristianou M., Toutouzas K., Chrisofos M., Giamarellos-Bourboulis E.J.
Fecha
2018
Language
en
DOI
10.1186/s12879-018-3156-z
Materia
abdominal infection
acute pyelonephritis
adult
aged
Article
bacteremia
cause of death
Charlson Comorbidity Index
clinical assessment
clinical feature
clinical outcome
community acquired pneumonia
comorbidity
controlled study
disease classification
disease exacerbation
female
human
infection control
major clinical study
male
mortality rate
prospective study
risk assessment
sepsis
systemic inflammatory response syndrome
abdominal infection
adolescent
biological variation
comorbidity
complication
disease exacerbation
Greece
infection
middle aged
pathology
risk factor
sepsis
systemic inflammatory response syndrome
very elderly
young adult
Adolescent
Adult
Aged
Aged, 80 and over
Biological Variation, Individual
Comorbidity
Disease Progression
Female
Greece
Humans
Infection
Intraabdominal Infections
Male
Middle Aged
Risk Factors
Sepsis
Systemic Inflammatory Response Syndrome
Young Adult
BioMed Central Ltd.
Mostrar el registro completo del ítem
Resumen
Background: Development of sepsis is a process with significant variation among individuals. The precise elements of this variation need to be defined. This study was designed to define the way in which comorbidities contribute to sepsis development. Methods: Three thousand five hundred nine patients with acute pyelonephritis (AP), community-acquired pneumonia (CAP), intraabdominal infections (IAI) or primary bacteremia (BSI) and at least two signs of the systemic inflammatory response syndrome were analyzed. The study primary endpoint was to define how comorbidities as expressed in the Charlson's comorbidity index (CCI) and the underlying type of infection contribute to development of organ dysfunction. The precise comorbidities that mediate sepsis development and risk for death among 18 comorbidities recorded were the secondary study endpoints. Results: CCI more than 2 had an odds ratio of 5.67 for sepsis progression in patients with IAI between significantly higher than AP and BSI. Forward logistic regression analysis indicated seven comorbidities that determine transition into sepsis in patients with AP, four comorbidities in CAP, six comorbidities in IAI and one in BSI. The odds ratio both for progression to sepsis and death with one comorbidity or with two and more comorbidities was greater than in the absence of comorbidities. Conclusions: The study described how different kinds of infection vary in the degree to which they lead to sepsis. The number of comorbidities that enhances the risk of sepsis and death varies depending on the underlying infections. © 2018 The Author(s).
URI
http://hdl.handle.net/11615/79010
Colecciones
  • Δημοσιεύσεις σε περιοδικά, συνέδρια, κεφάλαια βιβλίων κλπ. [19743]

Ítems relacionados

Mostrando ítems relacionados por Título, autor o materia.

  • Thumbnail

    Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis 

    Thomas K., Lazarini A., Kaltsonoudis E., Voulgari P.V., Drosos A.A., Repa A., Sali A.M.I., Sidiropoulos P., Tsatsani P., Gazi S., Evangelia A., Boki K.A., Katsimbri P., Boumpas D., Fragkiadaki K., Tektonidou M.G., Sfikakis P.P., Karagianni K., Sakkas L.I., Grika E.P., Vlachoyiannopoulos P.G., Evangelatos G., Iliopoulos A., Dimitroulas T., Garyfallos A., Melissaropoulos K., Georgiou P., Areti M., Georganas C., Vounotrypidis P., Georgiopoulos G., Kitas G.D., Vassilopoulos D. (2021)
    Objectives: Predicting serious infections (SI) in patients with rheumatoid arthritis (RA) is crucial for the implementation of appropriate preventive measures. Here we aimed to identify risk factors for SI and to validate ...
  • Thumbnail

    A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 

    Gutiérrez-Gutiérrez B., Salamanca E., de Cueto M., Pascual A., Rodríguez-Baño J., Hsueh P.-R., Viale P., Paño-Pardo J.R., Venditti M., Tumbarello M., Daikos G., Pintado V., Doi Y., Tuon F.F., Karaiskos I., Machuca I., Schwaber M.J., Azap Ö.K., Souli M., Roilides E., Pournaras S., Akova M., Pérez F., Bonomo R.A., Bermejo J., Oliver A., Almela M., Lowman W., Almirante B., Carmeli Y., Paterson D.L., Falcone M., Russo A., Giamarellou H., Trecarichi E.M., Losito A.R., García-Vázquez E., Hernández A., Gómez J., Iosifidis E., Prim N., Navarro F., Mirelis B., Origüen J., San Juan R., Fernández-Ruiz M., Larrosa N., Puig-Asensio M., Cisneros J.M., Molina J., González V., Rucci V., Ruiz de Gopegui E., Marinescu C.I., Martínez-Martínez L., Fariñas M.C., Cano M.E., Gozalo M., Mora-Rillo M., Navarro-San Francisco C., Peña C., Gómez-Zorrilla S., Tubau F., Tsakris A., Zarkotou O., Pitout J., Virmani D., Torre-Cisneros J., Natera C., Helvaci Ö., Sahin A.O., Cantón R., Ruiz P., Bartoletti M., Giannella M., Taconelli E., Riemenschneider F., Calbo E., Badia C., Xercavins M., Gasch E., Fontanals D., Jové E. (2016)
    Objective To develop a score to predict mortality in patients with bloodstream infections (BSIs) due to carbapenemase-producing Enterobacteriaceae (CPE). Patients and Methods A multinational retrospective cohort study ...
  • Thumbnail

    Ceftazidime/avibactam in the era of carbapenemase-producing Klebsiella pneumoniae: Experience from a national registry study 

    Karaiskos I., ikaraiskos@hygeia.gr, Daikos G.L., Gkoufa A., Adamis G., Stefos A., Symbardi S., Chrysos G., Filiou E., Basoulis D., Mouloudi E., Galani L., Akinosoglou K., Arvaniti K., Masgala A., Petraki M., Papadimitriou E., Galani I., Poulakou G., Routsi C., Giamarellou H. (2021)
    Background: Infections caused by KPC-producing Klebsiella pneumoniae (Kp) are associated with high mortality. Therefore, new treatment options are urgently required. Objectives: To assess the outcomes and predictors of ...
htmlmap 

 

Listar

Todo DSpaceComunidades & ColeccionesPor fecha de publicaciónAutoresTítulosMateriasEsta colecciónPor fecha de publicaciónAutoresTítulosMaterias

Mi cuenta

AccederRegistro
Help Contact
DepositionAboutHelpContacto
Choose LanguageTodo DSpace
EnglishΕλληνικά
htmlmap